BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 17566076)

  • 1. TNF-alpha interferes with lipid homeostasis and activates acute and proatherogenic processes.
    Fon Tacer K; Kuzman D; Seliskar M; Pompon D; Rozman D
    Physiol Genomics; 2007 Oct; 31(2):216-27. PubMed ID: 17566076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sterol metabolism and SREBP activation.
    Sato R
    Arch Biochem Biophys; 2010 Sep; 501(2):177-81. PubMed ID: 20541520
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulatory cross-talk between drug metabolism and lipid homeostasis: constitutive androstane receptor and pregnane X receptor increase Insig-1 expression.
    Roth A; Looser R; Kaufmann M; Blättler SM; Rencurel F; Huang W; Moore DD; Meyer UA
    Mol Pharmacol; 2008 Apr; 73(4):1282-9. PubMed ID: 18187584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis.
    Chakravarthy MV; Pan Z; Zhu Y; Tordjman K; Schneider JG; Coleman T; Turk J; Semenkovich CF
    Cell Metab; 2005 May; 1(5):309-22. PubMed ID: 16054078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-induced gene: a new regulator in lipid metabolism.
    Dong XY; Tang SQ
    Peptides; 2010 Nov; 31(11):2145-50. PubMed ID: 20817058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of dysregulation of low-density lipoprotein receptor expression in HepG2 cells induced by inflammatory cytokines.
    Chen YX; Ruan XZ; Huang AL; Li Q; Moorhead JF; Varghese Z
    Chin Med J (Engl); 2007 Dec; 120(24):2185-90. PubMed ID: 18167199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atypical antipsychotic drugs perturb AMPK-dependent regulation of hepatic lipid metabolism.
    Oh KJ; Park J; Lee SY; Hwang I; Kim JB; Park TS; Lee HJ; Koo SH
    Am J Physiol Endocrinol Metab; 2011 Apr; 300(4):E624-32. PubMed ID: 21224484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Molecular mechanism of fatty acids impact on plasma lipid profile (part II)].
    Swierczyński J; Chmielewski M; Wołyniec W; Rutkowski B
    Przegl Lek; 2007; 64(1):42-7. PubMed ID: 18183831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Calorie restriction modulates renal expression of sterol regulatory element binding proteins, lipid accumulation, and age-related renal disease.
    Jiang T; Liebman SE; Lucia MS; Phillips CL; Levi M
    J Am Soc Nephrol; 2005 Aug; 16(8):2385-94. PubMed ID: 15944339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential role of sterol regulatory element binding protein transcription factors in renal injury.
    Szolkiewicz M; Chmielewski M; Nogalska A; Stelmanska E; Swierczynski J; Rutkowski B
    J Ren Nutr; 2007 Jan; 17(1):62-5. PubMed ID: 17198935
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of lipid metabolism by soy protein and its implication in diseases mediated by lipid disorders.
    Torres N; Torre-Villalvazo I; Tovar AR
    J Nutr Biochem; 2006 Jun; 17(6):365-73. PubMed ID: 16481155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory stress exacerbates lipid-mediated renal injury in ApoE/CD36/SRA triple knockout mice.
    Xu ZE; Chen Y; Huang A; Varghese Z; Moorhead JF; Yan F; Powis SH; Li Q; Ruan XZ
    Am J Physiol Renal Physiol; 2011 Oct; 301(4):F713-22. PubMed ID: 21795641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor necrosis factor-alpha directly stimulates the overproduction of hepatic apolipoprotein B100-containing VLDL via impairment of hepatic insulin signaling.
    Qin B; Anderson RA; Adeli K
    Am J Physiol Gastrointest Liver Physiol; 2008 May; 294(5):G1120-9. PubMed ID: 18372392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic tissue sterol regulatory element binding protein 2 and low-density lipoprotein receptor in nephrotic syndrome.
    Kim CH; Kim HJ; Mitsuhashi M; Vaziri ND
    Metabolism; 2007 Oct; 56(10):1377-82. PubMed ID: 17884448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta.
    Marseille-Tremblay C; Ethier-Chiasson M; Forest JC; Giguère Y; Masse A; Mounier C; Lafond J
    Mol Reprod Dev; 2008 Jun; 75(6):1054-62. PubMed ID: 18095312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapamycin down-regulates LDL-receptor expression independently of SREBP-2.
    Sharpe LJ; Brown AJ
    Biochem Biophys Res Commun; 2008 Sep; 373(4):670-4. PubMed ID: 18602894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified HMG-CoA reductase and LDLr regulation is deeply involved in age-related hypercholesterolemia.
    Pallottini V; Martini C; Cavallini G; Donati A; Bergamini E; Notarnicola M; Caruso MG; Trentalance A
    J Cell Biochem; 2006 Aug; 98(5):1044-53. PubMed ID: 16741953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sphingolipids: major regulators of lipid metabolism.
    Worgall TS
    Curr Opin Clin Nutr Metab Care; 2007 Mar; 10(2):149-55. PubMed ID: 17285002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caloric restrictions affect some factors involved in age-related hypercholesterolemia.
    Martini C; Pallottini V; Cavallini G; Donati A; Bergamini E; Trentalance A
    J Cell Biochem; 2007 May; 101(1):235-43. PubMed ID: 17203467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SREBP-1c, regulated by the insulin and AMPK signaling pathways, plays a role in nonalcoholic fatty liver disease.
    Kohjima M; Higuchi N; Kato M; Kotoh K; Yoshimoto T; Fujino T; Yada M; Yada R; Harada N; Enjoji M; Takayanagi R; Nakamuta M
    Int J Mol Med; 2008 Apr; 21(4):507-11. PubMed ID: 18360697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.